181 related articles for article (PubMed ID: 18021252)
1. Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase.
Montin K; Cervellati C; Dallocchio F; Hanau S
FEBS J; 2007 Dec; 274(24):6426-35. PubMed ID: 18021252
[TBL] [Abstract][Full Text] [Related]
2. Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase.
Hanau S; d'Empaire LP; Capone I; Alberighi S; Montioli R; Dallocchio F
Biochim Biophys Acta; 2013 Dec; 1834(12):2647-52. PubMed ID: 24096100
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of a bacterial 6-phosphogluconate dehydrogenase reveal aspects of specificity, mechanism and mode of inhibition by analogues of high-energy reaction intermediates.
Sundaramoorthy R; Iulek J; Barrett MP; Bidet O; Ruda GF; Gilbert IH; Hunter WN
FEBS J; 2007 Jan; 274(1):275-86. PubMed ID: 17222187
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues.
Dardonville C; Rinaldi E; Barrett MP; Brun R; Gilbert IH; Hanau S
J Med Chem; 2004 Jun; 47(13):3427-37. PubMed ID: 15189039
[TBL] [Abstract][Full Text] [Related]
5. Energy cost for the proper ionization of active site residues in 6-phosphogluconate dehydrogenase from T. brucei.
Hanau S; Proietti d'Empaire L; Montin K; Cervellati C; Capone I; Dallocchio F
Biochim Biophys Acta; 2014 Apr; 1844(4):785-92. PubMed ID: 24568863
[TBL] [Abstract][Full Text] [Related]
6. A 2.8 A resolution structure of 6-phosphogluconate dehydrogenase from the protozoan parasite Trypanosoma brucei: comparison with the sheep enzyme accounts for differences in activity with coenzyme and substrate analogues.
Phillips C; Dohnalek J; Gover S; Barrett MP; Adams MJ
J Mol Biol; 1998 Sep; 282(3):667-81. PubMed ID: 9737929
[TBL] [Abstract][Full Text] [Related]
7. 6-Phosphogluconate dehydrogenase from Trypanosoma brucei. Kinetic analysis and inhibition by trypanocidal drugs.
Hanau S; Rippa M; Bertelli M; Dallocchio F; Barrett MP
Eur J Biochem; 1996 Sep; 240(3):592-9. PubMed ID: 8856059
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis.
Dardonville C; Rinaldi E; Hanau S; Barrett MP; Brun R; Gilbert IH
Bioorg Med Chem; 2003 Jul; 11(14):3205-14. PubMed ID: 12818683
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism.
Adams MJ; Ellis GH; Gover S; Naylor CE; Phillips C
Structure; 1994 Jul; 2(7):651-68. PubMed ID: 7922042
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of phosphate prodrugs of 4-phospho-D-erythronohydroxamic acid, an inhibitor of 6-phosphogluconate dehydrogenase.
Ruda GF; Alibu VP; Mitsos C; Bidet O; Kaiser M; Brun R; Barrett MP; Gilbert IH
ChemMedChem; 2007 Aug; 2(8):1169-80. PubMed ID: 17615587
[TBL] [Abstract][Full Text] [Related]
11. 6-Phosphogluconate dehydrogenase from Lactococcus lactis: a role for arginine residues in binding substrate and coenzyme.
Tetaud E; Hanau S; Wells JM; Le Page RW; Adams MJ; Arkison S; Barrett MP
Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):55-60. PubMed ID: 9931298
[TBL] [Abstract][Full Text] [Related]
12. Effect of the substrate on the binding of coenzyme and coenzyme analogues to 6-phosphogluconate dehydrogenase from Candida utilis.
Dallocchio F; Matteuzzi M; Bellini T
J Biol Chem; 1981 Nov; 256(21):10778-80. PubMed ID: 7197272
[TBL] [Abstract][Full Text] [Related]
13. Dehydrogenation by gluconate 6-phosphate dehydrogenase of an isosteric phosphonate substrate analogue.
Roach DJ; Harrison R
Biochem J; 1981 Sep; 197(3):731-5. PubMed ID: 7325981
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Pentose Phosphate Pathway: Characterization of a New 6PGL Inhibitor.
Tran AT; Sadet A; Calligari P; Lopes P; Ouazzani J; Sollogoub M; Miclet E; Abergel D
Biophys J; 2018 Dec; 115(11):2114-2126. PubMed ID: 30467026
[TBL] [Abstract][Full Text] [Related]
15. 6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species.
Rippa M; Giovannini PP; Barrett MP; Dallocchio F; Hanau S
Biochim Biophys Acta; 1998 Dec; 1429(1):83-92. PubMed ID: 9920387
[TBL] [Abstract][Full Text] [Related]
16. Cloning, purification, and characterization of the 6-phosphogluconate dehydrogenase (6 PGDH) from Giardia lamblia.
Morales-Luna L; Hernández-Ochoa B; Martínez-Rosas V; González-Valdez A; Cárdenas-Rodríguez N; Enríquez-Flores S; Marcial-Quino J; Gómez-Manzo S
Mol Biochem Parasitol; 2021 Jul; 244():111383. PubMed ID: 34048823
[TBL] [Abstract][Full Text] [Related]
17. 6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes.
Hanau S; Rinaldi E; Dallocchio F; Gilbert IH; Dardonville C; Adams MJ; Gover S; Barrett MP
Curr Med Chem; 2004 Oct; 11(19):2639-50. PubMed ID: 15544466
[TBL] [Abstract][Full Text] [Related]
18. The 6-phosphogluconate dehydrogenase from Trypanosoma cruzi: the absence of two inter-subunit salt bridges as a reason for enzyme instability.
Esteve MI; Cazzulo JJ
Mol Biochem Parasitol; 2004 Feb; 133(2):197-207. PubMed ID: 14698432
[TBL] [Abstract][Full Text] [Related]
19. Global effects of the energetics of coenzyme binding: NADPH controls the protein interaction properties of human cytochrome P450 reductase.
Grunau A; Paine MJ; Ladbury JE; Gutierrez A
Biochemistry; 2006 Feb; 45(5):1421-34. PubMed ID: 16445284
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Plasmodium falciparum 6-Phosphogluconate Dehydrogenase as an Antimalarial Drug Target.
Haeussler K; Fritz-Wolf K; Reichmann M; Rahlfs S; Becker K
J Mol Biol; 2018 Oct; 430(21):4049-4067. PubMed ID: 30098336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
